losartan and celiprolol

losartan has been researched along with celiprolol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bakker, ENTP; Carrel, T; Caspar, SM; Crabb, J; Dubacher, N; Gorosabel, MC; Ksiazek, AA; Matyas, G; Meienberg, J; Münger, J; Steinmann, B; van Bavel, E; Zeisberger, S; Ziegler, U	1

Other Studies

1 other study(ies) available for losartan and celiprolol

Article	Year
Celiprolol but not losartan improves the biomechanical integrity of the aorta in a mouse model of vascular Ehlers-Danlos syndrome. Cardiovascular research, 2020, 02-01, Volume: 116, Issue:2 Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Aortic Rupture; Celiprolol; Collagen Type III; Doxycycline; Ehlers-Danlos Syndrome; Heterozygote; Losartan; Matrix Metalloproteinase Inhibitors; Mice, Inbred C57BL; Mutation; Proof of Concept Study; Stress, Mechanical; Vascular Remodeling	2020

Article

Year

Celiprolol but not losartan improves the biomechanical integrity of the aorta in a mouse model of vascular Ehlers-Danlos syndrome.

Cardiovascular research, 2020, 02-01, Volume: 116, Issue:2

Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Aortic Rupture; Celiprolol; Collagen Type III; Doxycycline; Ehlers-Danlos Syndrome; Heterozygote; Losartan; Matrix Metalloproteinase Inhibitors; Mice, Inbred C57BL; Mutation; Proof of Concept Study; Stress, Mechanical; Vascular Remodeling

2020